Johnson & Johnson (NYSE: JNJ) announced today that it intends to separate its DePuy Synthes Orthopaedics business.

Johnson & Johnson (JNJ) on Tuesday announced its intent to separate its Orthopedic business. The company said that it will ...

J&J CEO Joaquin Duato told investors this week that the orthopedics spinoff would allow J&J to focus on faster-growing ...

Johnson & Johnson is planning to separate its orthopedic business, which will operate as DePuy Synthes, according to an Oct. 14 news release. Namal Nawana, former executive chair and founder of ...

Two years after spinning off its $15 billion consumer health unit as Kenvue, Johnson & Johnson is slimming down again by ...

Johnson and Johnson is the latest medtech company to announce plans to segment its orthopedic business into its own company. It is the latest in a recent trend of medtech companies parting ways with ...

Moments after the Seattle Mariners advanced to the American League Championship Series with a thrilling 15-inning win over ...

Johnson & Johnson ( NYSE: JNJ) Q3 2025 Earnings Call October 14, 2025 8:30 AM EDT Good morning, and welcome to Johnson & Johnson's Third Quarter 2025 Earnings Conference Call. [Operator Instructions] ...

Like many independent practices, Olympia Orthopaedic Associates faces administrative bottlenecks with front-office staff handling manual, time-consuming tasks like managing referrals. It's not the ...

Neck and shoulder pain can occur due to poor posture, muscle strains, and more. Certain exercises can help relieve this pain, ...

The settlement was reached about a week after the third layer of insurance coverage entered the negotiations. The first layer ...

Q3 2025 Earnings Call Transcript October 14, 2025 Johnson & Johnson beats earnings expectations. Reported EPS is $2.8, ...